SB 239 Alabama Senate · 2023 Regular Session

Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.

Summary
Medication Assisted Treatment of Opioid Use Act, repealed
Bill status signed all 5 stages cleared
Introduction
Apr 2023
Committee Review
May 2023
Senate Passage
May 2023
House Passage
May 2023
Signed into Law
Jun 2023
Introduced Apr 25, 2023 Signed Jun 1, 2023
Floor votes · Senate May 3, 2023 · House May 18, 2023

How they voted

300
Passed · 4 other
Total votes 34
May 3, 2023
D Democratic8
6 Yea 2
75% Yea
R Republican26
24 Yea 2
92% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
17
Key actions
6
Committee
5
May 18, 2023
Lower · Passed
Read a Third Time and Pass
lower
May 10, 2023
Lower · Passed
Reported Out of Committee in Second House
lower
May 10, 2023
Lower · Passed
Reported Favorably (Health)
lower
May 4, 2023
Committee
Referred to Committee (Health)
lower
May 3, 2023
Upper · Passed
Read a Third Time and Pass
upper
Apr 26, 2023
Upper · Passed
Reported Out of Committee in House of Origin
upper
Apr 26, 2023
Upper · Passed
Reported Favorably (Healthcare)
upper
Apr 25, 2023
Introduced
Introduced and Referred (Healthcare)
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Larry Stutts
Larry Stutts
RRepublican
AL
6